Different mechanisms of intrinsic pain inhibition in early and late inflammation

Journal of Neuroimmunology

Volumn 141, Issue 1-2, 2003, Pages 30-39

  Machelska, Halina ^a   Schopohl, Julia K ^a   Mousa, Shaaban A ^a   Labuz, Dominika ^a   Schäfer, Michael ^a   Stein, Christoph ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Analgesia; Antinociception; Immune cells; Inflammation; Opioid peptides; Opioid receptors; Pain

Indexed keywords

BETA ENDORPHIN; CORTICOTROPIN RELEASING FACTOR; DYNORPHIN A; METENKEPHALIN; OPIATE ANTAGONIST; OPIATE PEPTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; DRUG EFFECT; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; MALE; NEUROIMMUNOLOGY; NOCICEPTION; NONHUMAN; PAW EDEMA; PRIORITY JOURNAL; RAT; STATISTICAL SIGNIFICANCE;

EID: 0142043848     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(03)00213-3     Document Type: Article

References (34)

1. Basbaum A.I., Fields H.L. Endogenous pain control systems: brainstem spinal pathways and endorphin circuitry. Annu. Rev. Neurosci. 7:1984;309-338.
2. Braz J., Beaufour C., Coutaux A., Epstein A.L., Cesselin F., Hamon M., Pohl M. Therapeutic efficacy in experimental polyarthritis of viral-driven enkephalin overproduction in sensory neurons. J. Neurosci. 21:2001;7881-7888.
3. Cabot P.J., Carter L., Gaiddon C., Zhang Q., Schäfer M., Loeffler J.P., Stein C. Immune cell-derived β-endorphin: production, release and control of inflammatory pain in rats. J. Clin. Invest. 100:1997;142-148.
4. Cabot P.J., Carter L., Schäfer M., Stein C. Methionine-enkephalin- and dynorphin A-release from immune cells and control of inflammatory pain. Pain. 93:2001;207-212.
5. Hassan A.H., Pzewlocki R., Herz A., Stein C. Dynorphin, a preferential ligand for kappa-opioid receptors, is present in nerve fibers and immune cells within inflamed tissue of the rat. Neurosci. Lett. 140:1992;85-88.
6. Hassan A.H.S., Ableitner A., Stein C., Herz A. Inflammation of the rat paw enhances axonal transport of opioid receptors in the sciatic nerve and increases their density in the inflamed tissue. Neuroscience. 55:1993;185-195.
7. Ji R.R., Zhang Q., Law P.Y., Low H.H., Elde R., Hokfelt T. Expression of mu-, delta-, and kappa-opioid receptor-like immunoreactivities in rat dorsal root ganglia after carrageenan-induced inflammation. J. Neurosci. 15:1995;8156-8166.
8. Jordan B.A., Cvejic S., Devi L.A. Opioids and their complicated receptor complexes. Neuropsychopharmacology. 23(4 Suppl.):2000;S5-S18.
9. Machelska H., Stein C. Immune mechanisms in pain control. Anesth. Analg. 95:2002;1002-1008.
10. Machelska H., Cabot P.J., Mousa S.A., Zhang Q., Stein C. Pain control in inflammation governed by selectins. Nat. Med. 4:1998;1425-1428.
11. Machelska H., Mousa S.A., Brack A., Schopohl J.K., Rittner H.L., Schäfer M., Stein C. Opioid control of inflammatory pain regulated by intercellular adhesion molecule-1. J. Neurosci. 22:2002;5588-5596.
12. Mansour A., Fox C.A., Akil H., Watson S.J. Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications. Trends Neurosci. 18:1995;22-29.
13. Mousa S.A., Schafer M., Mitchell W.M., Hassan A.H.S., Stein C. Local upregulation of corticotropin-releasing hormone and interleukin-1 receptors in rats with painful hindlimb inflammation. Eur. J. Pharmacol. 311:1996;221-231.
14. Mousa S.A., Zhang Q., Sitte N., Ji R.-R., Stein C. β-Endorphin containing memory-cells and μ-opioid receptors undergo site-directed transport into peripheral inflamed tissue. J. Neuroimmunol. 115:2001;71-78.
15. Nabeshima T., Yamada K., Kameyama T. Contribution of different opioid systems to footshock-induced analgesia and motor suppression. Eur. J. Pharmacol. 92:1983;199-205.
16. Parsons C.G., Czlonkowski A., Stein C., Herz A. Peripheral opioid receptors mediating antinociception in inflammation. Activation by endogenous opioids and role of the pituitary-adrenal axis. Pain. 41:1990;81-93.
17. Pliska V. Models to explain dose-response relationships that exhibit a downturn phase. Trends Pharmacol. Rev. 15:1994;178-181.
18. Pohl M., Braz J. Gene therapy of pain: emerging strategies and future directions. Eur. J. Pharmacol. 429:2001;39-48.
19. Przewlocki R., Hassan A.H.S., Lason W., Epplen C., Herz A., Stein C. Gene expression and localization of opioid peptides in immune cells of inflamed tissue. Functional role in antinociception. Neuroscience. 48:1992;491-500.
20. Rittner H.L., Brack A., Machelska H., Mousa S.A., Bauer M., Schäfer M., Stein C. Opioid peptide-expressing leukocytes: identification, recruitment, and simultaneously increasing inhibition of inflammatory pain. Anesthesiology. 95:2001;500-508.
21. Rubinstein M., Mogil J.S., Japon M., Chan E.C., Allen R.G., Low M.J. Absence of opioid stress-induced analgesia in mice lacking beta-endorphin by site-directed mutagenesis. Proc. Natl. Acad. Sci. U. S. A. 93:1996;3995-4000.
22. Schäfer M., Carter L., Stein C. Interleukin-1 beta and corticotropin-releasing-factor inhibit pain by releasing opioids from immune cells in inflamed tissue. Proc. Natl. Acad. Sci. U. S. A. 91:1994;4219-4223.
23. Schäfer M., Imai Y., Uhl G.R., Stein C. Inflammation enhances peripheral mu-opioid receptor-mediated analgesia, but not mu-opioid receptor transcription in dorsal root ganglia. Eur. J. Pharmacol. 279:1995;165-169.
24. Schäfer M., Mousa S.A., Zhang Q., Carter L., Stein C. Expression of corticotropin-releasing factor in inflamed tissue is required for intrinsic peripheral opioid analgesia. Proc. Natl. Acad. Sci. U. S. A. 93:1996;6096-6100.
25. Singer A.J., Clark R.A. Cutaneous wound healing. N. Engl. J. Med. 341:1999;738-746.
26. Shannon H.E., Lutz E.A. Comparison of the peripheral and central effects of the opioid agonists loperamide and morphine in the formalin test in rats. Neuropharmacology. 42:2002;253-261.
27. Smith, E.M., 2003. Opioid peptides in immune cells. In: Machelska, H., Stein, C. (Eds.), Immune Mechanisms of Pain and Analgesia, Landes Bioscience, Georgetown and Kluwer Academic, New York, pp. 51-68.
28. Starec M., Rosina J., Malek J., Krsiak M. Influence of dynorphin A (1-13) and dynorphin A (1-10) amide on stress-induced analgesia. Physiol. Res. 45:1996;433-438.
29. Stein C., Gramsch C., Herz A. Intrinsic mechanisms of analgesia in inflammation: local opioid receptors and β-endorphin. J. Neurosci. 10:1990;1292-1298.
30. Stein C., Hassan A.H.S., Przewlocki R., Gramsch C., Peter K., Herz A. Opioids form immunocytes interact with receptors on sensory nerves to inhibit nociception in inflammation. Proc. Natl. Acad. Sci. U. S. A. 87:1990;5935-5939.
31. Stein C., Hassan A.H.S., Lehrberger K., Giefing J., Yassouridis A. Local analgesic effect of endogenous opioid peptides. Lancet. 342:1993;321-324.
32. Stein C., Pflüger M., Yassouridis A., Hoelzl J., Lehrberger K., Welte C., Hassan A.H.S. No tolerance to peripheral morphine analgesia in presence of opioid expression in inflamed synovia. J. Clin. Invest. 98:1996;793-799.
33. Terman G.W., Shavit Y., Lewis J.W., Cannon J.T., Liebeskind J.C. Intrinsic mechanisms of pain inhibition: activation by stress. Science. 14:1984;1270-1277.
34. Willer J.C., Dehen H., Cambier J. Stress-induced analgesia in humans: endogenous opioids and naloxone-reversible depression of pain reflexes. Science. 212:1981;689-691.